Preoperative Chemotherapy vs. Chemoradiation in Esophageal / GEJ Adenocarcinoma

NCT01404156 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Adenocarcinoma, Esophageal
Adenocarcinoma, Gastroesophageal Junction

Interventions

DRUG: (Epirubicin Cisplatin 5-Fluorouracil / Xeloda) OR 5-Fluorouracil Leucovorin Oxaliplatin Docetaxel
OTHER: Carboplatin paclitaxel plus concurrent radiotherapy

Sponsor

Dr. Gordon Buduhan

Collaborators

[object Object]
[object Object]
[object Object]